Literature DB >> 30543839

Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.

Wade T Iams1, Kathryn E Beckermann1, Karinna Almodovar2, Jennifer Hernandez3, Cindy Vnencak-Jones4, Lee P Lim3, Christopher K Raymond3, Leora Horn1, Christine M Lovly5.   

Abstract

Entities:  

Year:  2018        PMID： 30543839      PMCID： PMC6382512          DOI： 10.1016/j.jtho.2018.11.031

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  12 in total

1.  A Tale of Two Histologies: Dissecting the Biology of Lineage Transformation in Lung Cancer.

Authors:  Catherine B Meador; Christine M Lovly
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

2.  Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.

Authors:  Mingrui Zhu; Yi Huang; Matthew E Bender; Luc Girard; Rahul Kollipara; Buse Eglenen-Polat; Yujiro Naito; Trisha K Savage; Kenneth E Huffman; Shohei Koyama; Atsushi Kumanogoh; John D Minna; Jane E Johnson; Esra A Akbay
Journal:  Cancer Res       Date:  2021-01-25       Impact factor: 13.312

3.  Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

Authors:  Kartik Sehgal; Andreas Varkaris; Hollis Viray; Paul A VanderLaan; Deepa Rangachari; Daniel B Costa
Journal:  J Immunother Cancer       Date:  2020-06-23       Impact factor: 13.751

4.  Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.

Authors:  Naoko Miura; Taichi Matsubara; Shinkichi Takamori; Naoki Haratake; Ryo Toyozawa; Masafumi Yamaguchi; Takashi Seto; Kenichi Taguchi; Mitsuhiro Takenoyama
Journal:  Oxf Med Case Reports       Date:  2020-05-23

Review 5.  How should molecular findings be integrated in the classification for lung cancer?

Authors:  Yin P Hung; Lucian R Chirieac
Journal:  Transl Lung Cancer Res       Date:  2020-10

Review 6.  Pathology and Classification of SCLC.

Authors:  Maria Gabriela Raso; Neus Bota-Rabassedas; Ignacio I Wistuba
Journal:  Cancers (Basel)       Date:  2021-02-16       Impact factor: 6.639

7.  Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases.

Authors:  Qian Shen; Jingjing Qu; Lingyan Sheng; Qiqi Gao; Jianying Zhou
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

Review 8.  The cutting-edge progress of immune-checkpoint blockade in lung cancer.

Authors:  Fei Zhou; Meng Qiao; Caicun Zhou
Journal:  Cell Mol Immunol       Date:  2020-11-11       Impact factor: 22.096

9.  Histologic transformation of lung cancer during pembrolizumab therapy: A case report.

Authors:  Xiaoyan Si; Yan You; Xiaotong Zhang; Hanping Wang; Mengzhao Wang; Li Zhang
Journal:  Thorac Cancer       Date:  2020-01-16       Impact factor: 3.500

10.  Is transformed small cell lung cancer (SCLC) different from de novo SCLC?

Authors:  Cheol-Kyu Park; In-Jae Oh; Young-Chul Kim
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.